IL1B and hyperlipidemia: In addition, the results of biological activity experiments have shown that FVPT1 exhibits good immunomodulatory activity by increasing nitric oxide, interleukin (IL)-1β and IL-1 secretion in macrophages and good hypolipidemic activity via appreciable lipid-lowering effects in a zebrafish larva hyperlipidemia model test.